Premium
Challenges in Increasing Access to Buprenorphine Treatment for Opiate Addiction
Author(s) -
West Joyce C.,
Kosten Thomas R.,
Wilk Joshua,
Svikis Dace,
Triffleman Elise,
Rae Donald S.,
Narrow William E.,
Duffy Farifteh F.,
Regier Darrel A.
Publication year - 2004
Publication title -
the american journal on addictions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.997
H-Index - 76
eISSN - 1521-0391
pISSN - 1055-0496
DOI - 10.1080/10550490490440753
Subject(s) - buprenorphine , addiction treatment , addiction , substance abuse , medicine , psychiatry , opiate , opiate substitution treatment , addiction medicine , family medicine , opioid , receptor
The aims of this study are to assess psychiatrists' comfort using office‐based opiate agonist treatment (OBOT) and to identify psychiatrist characteristics associated with OBOT comfort. A random sample of 2,323 AMA Master‐file of Physicians psychiatrists were surveyed through the 2002 APIRE National Survey of Psychiatric Practice (NSSP). Of the 52% responding (N= 1,203), 80.6% (SE = 1.8%) were not comfortable providing OBOT. Males, addiction‐certified psychiatrists, and those treating substance abuse patients were more comfortable providing OBOT. These findings highlight significant barriers in providing buprenorphine treatment. Increasing the understanding of specific financing and services delivery barriers that clinicians face is needed to inform the development of effective integrated services models and policies to facilitate OBOT implementation.